Search Browse Earnings

Akoya Biosciences, Inc.

Laboratory Analytical Instruments·MARLBOROUGH, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$96.6M

+29.1% YoY

FY 2024

Adj. EBITDA

-$48.8M

-50.5% margin

FY 2024

Net Income

-$63.3M

-65.5% margin

FY 2024

EPS (Diluted)

-$1.43

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$83.1M

FY 2024

Total Debt

$75.3M

FY 2024

Net Cash

$7.9M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

—

Employees

—

CEO

Mckelligon Brian

CFO

Ek John Frederick